Celsion's heat-reactive liposomes in liver cancer tests
This article was originally published in Clinica
Executive Summary
The US National Institutes of Health (NIH) is to test whether targeted delivery of a cancer-killing drug using Celsion's temperature-sensitive liposomes can improve the treatment of liver cancer.